A Phase 2, Multi-Center, Open Label, Simon Two-Stage Study to Evaluate the Safety and Efficacy of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
Phase of Trial: Phase II
Latest Information Update: 22 Mar 2017
At a glance
- Drugs Fostamatinib (Primary)
- Indications Autoimmune haemolytic anaemia
- Focus Proof of concept; Therapeutic Use
- Acronyms SOAR
- Sponsors Rigel Pharmaceuticals
- 07 Mar 2017 According to a Rigel media release, the company expects to complete enrollment and have results from this study in 2017.
- 01 Nov 2016 According to a Rigel Pharmaceuticals media release, results of the Stage 1 segment of the trial are expected in 2017.
- 03 May 2016 According to Rigel Pharmaceuticals media release, the results of the study will be forthcoming later this year (2016).